Drug
Atazanavir
Atazanavir: highest development phase Post-Market, developed by Bristol-Myers Squibb, Viatris. 4 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bristol-Myers Squibb, Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| Atazanavir NCT00312754 | Post-Market | HIV Infections |
| ATAZANAVIR SULFATE | Approved | |
| EVOTAZ | Approved | |
| REYATAZ | Approved |
Latest
No recent events.
Follow Atazanavir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.